| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.064 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.063 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |